Phase III trial of lurbinectedin versus PLD or topotecan in platinum-resistant ovarian cancer patients: Results of CORAIL trial

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Gaillard, S; Oaknin, A; Ray-Coquard, IL; Vergote, IB; Scambia, G; Colombo, N; Ghamande, SA; Soto-Matos, A; Fernandez, CM; Kahatt, C; Gomez, J; Nieto, A; Torres, N; Pardo-Burdalo, B; Papai, Z; Kristeleit, RS; O'Malley, DM; Benjamin, I; Pautier, P; Lorusso, D

Published Date

  • October 1, 2018

Published In

Volume / Issue

  • 29 /

Start / End Page

  • viii332 -

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdy285

Citation Source

  • Scopus